Therefore, we propose that SLC1A5 may induce immune suppression in glioblastoma through mechanisms involving T-cell exhaustion, upregulation of PD-L1, and the accumulation of Tregs and MDSCs. The gene discussed is SLC1A5; the disease is glioblastoma.